DANA Inc: Form 10-Q for the period ended Mar 31, 2022
Filed with the SEC on Apr 28, 2022 and accepted by EDGAR at Apr 28, 2022, 16:14 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2022-03-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2022-01-01 to 2022-03-31 | $2.48bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months2022-01-01 to 2022-03-31 | $2.28bn | us-gaap:CostOfGoodsAndServicesSold |
| Selling, general and administrative | 3 months2022-01-01 to 2022-03-31 | $130.0m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2022-01-01 to 2022-03-31 | $66.0m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2022-01-01 to 2022-03-31 | $31.0m | us-gaap:InterestExpense |
| Income tax | 3 months2022-01-01 to 2022-03-31 | $18.0m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2022-01-01 to 2022-03-31 | $17.0m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2022-01-01 to 2022-03-31 | $0.12 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2022-01-01 to 2022-03-31 | $0.12 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2022-01-01 to 2022-03-31 | 145,300,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 3 months2022-01-01 to 2022-03-31 | −$121.0m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 3 months2022-01-01 to 2022-03-31 | $116.0m | us-gaap:PaymentsToAcquireProductiveAssets |
| Dividends paid | 3 months2022-01-01 to 2022-03-31 | $14.0m | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 3 months2022-01-01 to 2022-03-31 | $25.0m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2022-03-31 | $259.0m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2022-03-31 | $3.99bn | us-gaap:AssetsCurrent |
| Total assets | At period end2022-03-31 | $8.05bn | us-gaap:Assets |
| Current liabilities | At period end2022-03-31 | $2.62bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2022-03-31 | $5.87bn | us-gaap:Liabilities |
| Short-term borrowings | At period end2022-03-31 | $301.0m | us-gaap:ShortTermBorrowings |
| Shareholders' equity | At period end2022-03-31 | $1.93bn | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001437749-22-010084. Last ingested by Listed: Oct 29, 2026, 04:34 ET. Listed shows no prices and gives no investment advice.